Author: swiss-user
Bern scientists develop individualized cancer models to predict therapy success
Scientists at the University of Bern and Inselspital have established organoid culture models from prostate tumor biopsies. These are small clusters of cells which can be used to test the efficacy of various drugs, helping to test which treatment will most likely benefit individual patients.
March 10, 2021
Aging brain can be reactivated
Zurich – Neuroscientists have discovered a mechanism that is partly responsible for the decrease in memory performance brought about by old age. They have also shown how nerve cell generation can be reactivated, which could benefit people with Alzheimer’s disease, for instance.
February 25, 2021
Medacta offering personalized solutions for hip replacement surgery
Castel San Pietro TI – The prosthetic specialist Medacta has developed two applications for personalized hip replacement operations. The first facilitates preoperative planning in 3D, while the second verifies exact positioning during surgery. The products have now also received clearance from the US FDA.
February 16, 2021
First patient treated with drug developed by Orpha Labs
Baar ZG – This week, the first patient was treated in Israel with a drug developed by Orpha Labs to combat the rare disorder leukocyte adhesion deficiency type II (LAD II). In particularly serious cases, a special program can be used to grant patients access to this new, highly promising drug even before it has been officially authorized.
February 9, 2021
Women’s Health focused company chooses Lucerne, Switzerland
This past February 2021, Merck & Co. established the Headquarters for Organon & Co. a standalone, spin-off company dedicated to global leadership in women’s health. This move adds 150-200 jobs to Lucerne’s biopharma ecosystem.
January 27, 2021
B.Braun manufacturing COVID-19 vaccination sets in Lucerne
Lucerne – Together with two governmental departments in Switzerland, B. Braun Medical AG has designed COVID-19 vaccination sets for hospitals. The MedTech manufacturer has procured the individual components and has been assembling the sets at its locations in Sempach and Crissier since December 2020.
January 18, 2021
Novocure cancer therapy chooses Lucerne for Swiss EMEA Headquarters
Novocure is a commercial-stage oncology company dedicated to the advancement of TTF therapy (Tumor Treating Fields) for patients with solid tumors.
January 1, 2021
Lonza manufactures coronavirus vaccine for Moderna
Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the initial results from a phase 3 study, according to which the vaccine candidate is 94.5 percent effective. Moderna opened a subsidiary in Basel to drive forward the production of the vaccine from there.
November 17, 2020
Switzerland-based data-driven medicine leader raises $110 million
Global leader in data-driven medicine SOPHiA GENETICS has closed a $110 million financing round to enter the next stage of its expansion, with a focus on supporting the growing clinical and biopharma demand for data-driven medicine worldwide.
October 6, 2020
Neubio produces innovative cochlear implants in Biel
Hailing from the United States, the start-up established its global headquarters in Biel in May 2017 to manufacture and sell cochlear implants and hearing aids for the worldwide hearing-impaired market.
June 7, 2018
NeoGenomics establishes its European headquarters in Switzerland
Supported and assisted by the GGBa, the U.S.-based company NeoGenomics has established its regional headquarters in Rolle, in the canton of Vaud. With a turnover of $250 million in 2016, the NASDAQ-listed multinational is a premier cancer diagnostics and pharma services company. Founded in 2001 in Florida, it employs 1,000 people in the United States and has now decided to tackle the European market.
June 26, 2017